CAS: 1246816-28-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Acipimox-d4 REF: 4Z-A-337002CAS: 1246816-28-3 | - - - | To inquire | Mon 23 Dec 24 |
 | Acipimox-d4 REF: TR-A189852CAS: 1246816-28-3 | - - - | 232.00 €~1,597.00 € | Fri 27 Dec 24 |
 | Acipimox-d4 REF: 3D-WZB81628CAS: 1246816-28-3 | Min. 95% | To inquire | Mon 27 Jan 25 |
Ref: 4Z-A-337002
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 23 Dec 2024
Acipimox-d4
Controlled ProductCAS:1246816-28-3
Applications Labelled antilipemic. References Fuccella, L.M., et al.: Clin. Pharmacol. Ther., 28, 790 (1980), Lovisolo, …
Formula:
C6H2D4N2O3
Color and Shape:
Off-White To Beige
Molecular weight:
158.15
Ref: TR-A189852
| 1mg | 232.00 € | ||
| 10mg | 1,597.00 € |
Estimated delivery in United States, on Friday 27 Dec 2024
Acipimox-d4
CAS:1246816-28-3
Please enquire for more information about Acipimox-d4 including the price, delivery time and more detailed …
Formula:
C6H6N2O3
Purity:
Min. 95%
Molecular weight:
158.15 g/mol
Ref: 3D-WZB81628
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 27 Jan 2025
